RA CAPITAL MANAGEMENT, L.P. purchased 81.8% of their position (2.84M shares) of HEMAB THERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $52.22M — a major conviction buy. The strongest form of insider conviction signal.
Common Stock
Shares
+3.61M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.01M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+221.19K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+2.54M
Price / share
$18.00
Trade value
$45.74M
% of position
Common Stock
Shares
+133.75K
Price / share
$18.00
Trade value
$2.41M
% of position
Common Stock
Shares
+87.14K
Price / share
$24.59
Trade value
$2.14M
% of position
Common Stock
Shares
+10.27K
Price / share
$25.00
Trade value
$256.70K
% of position
Common Stock
Shares
+14.61K
Price / share
$23.77
Trade value
$347.30K
% of position
Common Stock
Shares
+53.41K
Price / share
$24.83
Trade value
$1.33M
% of position
Net shares
+7.68M
Net value
$52.22M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/4/2026 | C · Conversion | +3.61M | — | — | New position | 0.00 | 3.61M |
| Common Stock Indirect | 5/4/2026 | C · Conversion | +1.01M | — | — | New position | 0.00 | 1.01M |
| Common Stock Indirect | 5/4/2026 | C · Conversion | +221.19K | — | — | New position | 0.00 | 221.19K |
| Common Stock Indirect | 5/4/2026 | P · Purchase | +2.54M | $18.00 | $45.74M | 70.4% | 3.61M | 6.15M |
| Common Stock Indirect | 5/4/2026 | P · Purchase | +133.75K | $18.00 | $2.41M | 60.5% | 221.19K | 354.94K |
| Common Stock Indirect | 5/5/2026 | P · Purchase | +87.14K | $24.59 | $2.14M | 1.4% | 6.15M | 6.24M |
| Common Stock Indirect | 5/5/2026 | P · Purchase | +10.27K | $25.00 | $256.70K | 0.2% | 6.24M | 6.25M |
| Common Stock Indirect | 5/6/2026 | P · Purchase | +14.61K | $23.77 | $347.30K | 0.2% | 6.25M | 6.26M |
| Common Stock Indirect | 5/6/2026 | P · Purchase | +53.41K | $24.83 | $1.33M | 0.9% | 6.26M | 6.31M |
| Total | +7.68M | $52.22M | ||||||
Series A Preferred Stock
Common Stock
1.42M shares
Shares
−64.68K
Strike price
Held after
0.00
Exercisable
—
Series A Preferred Stock
Common Stock
609.84K shares
Shares
−27.72K
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
931.50K shares
Shares
−42.34K
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
399.21K shares
Shares
−18.15K
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Common Stock
1.25M shares
Shares
−56.97K
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Common Stock
221.19K shares
Shares
−10.05K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock1.42M shares | 5/4/2026 | C · Conversion | −64.68K | — | 0.00 | |
| Series A Preferred Stock Indirect | Common Stock609.84K shares | 5/4/2026 | C · Conversion | −27.72K | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock931.50K shares | 5/4/2026 | C · Conversion | −42.34K | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock399.21K shares | 5/4/2026 | C · Conversion | −18.15K | — | 0.00 | |
| Series C Preferred Stock Indirect | Common Stock1.25M shares | 5/4/2026 | C · Conversion | −56.97K | — | 0.00 | |
| Series C Preferred Stock Indirect | Common Stock221.19K shares | 5/4/2026 | C · Conversion | −10.05K | — | 0.00 |